Literature DB >> 26224932

Stability of 47Sc-complexes with acyclic polyamino-polycarboxylate ligands.

Magdalena Połosak1, Agata Piotrowska1, Seweryn Krajewski1, Aleksander Bilewicz1.   

Abstract

The aim of this study was to evaluate acyclic ligands which can be applied for labeling proteins such as monoclonal antibodies and their fragments with scandium radionuclides. Recently, scandium isotopes (47Sc, 44Sc) are more available and their properties are convenient for radiotherapy or PET imaging. They can be used together as "matched pair" in theranostic approach. Because proteins denaturize at temperature above 42 °C, ligands which efficiently form complexes at room temperature, are necessary for labelling such biomolecules. For complexation of scandium radionuclides open chain ligands DTPA, HBED, BAPTA, EGTA, TTHA and deferoxamine have been chosen. We found that the ligands studied (except HBED) form strong complexes within 10 min and that the radiolabelling yield varies between 96 and 99 %. The complexes were stable in isotonic NaCl, but stability of 46Sc-TTHA, 46Sc-BAPTA and 46Sc-HBED in PBS buffer was low, due to formation by Sc3+stronger complexes with phosphates than with the studied ligands. From the radiolabelling studies with n.c.a. 47Sc we can conclude that the most stable complexes are formed by the 8-dentate DTPA and EGTA ligands.

Entities:  

Keywords:  Acyclic multidentate ligands; Scandium radionuclides; Targeted therapy

Year:  2012        PMID: 26224932      PMCID: PMC4514464          DOI: 10.1007/s10967-012-2188-x

Source DB:  PubMed          Journal:  J Radioanal Nucl Chem        ISSN: 0236-5731            Impact factor:   1.371


  8 in total

1.  Radiolabeling of DOTATOC with the long-lived positron emitter 44Sc.

Authors:  Marek Pruszyński; Agnieszka Majkowska-Pilip; Natalia S Loktionova; Elisabeth Eppard; Frank Roesch
Journal:  Appl Radiat Isot       Date:  2012-03-18       Impact factor: 1.513

2.  Radiochemical purification of no-carrier-added scandium-47 for radioimmunotherapy.

Authors:  K L Kolsky; V Joshi; L F Mausner; S C Srivastava
Journal:  Appl Radiat Isot       Date:  1998-12       Impact factor: 1.513

Review 3.  Radionuclide development at BNL for nuclear medicine therapy.

Authors:  L F Mausner; K L Kolsky; V Joshi; S C Srivastava
Journal:  Appl Radiat Isot       Date:  1998-04       Impact factor: 1.513

4.  A process for the separation of 177Lu from neutron irradiated 176Yb targets.

Authors:  E P Horwitz; D R McAlister; A H Bond; R E Barrans; J M Williamson
Journal:  Appl Radiat Isot       Date:  2005-04-15       Impact factor: 1.513

5.  Macrocyclic complexes of scandium radionuclides as precursors for diagnostic and therapeutic radiopharmaceuticals.

Authors:  A Majkowska-Pilip; A Bilewicz
Journal:  J Inorg Biochem       Date:  2010-11-13       Impact factor: 4.155

6.  Radiochemical separation of no-carrier-added 177Lu as produced via the 176Yb(n,gamma)177Yb-->177Lu process.

Authors:  N A Lebedev; A F Novgorodov; R Misiak; J Brockmann; F Rösch
Journal:  Appl Radiat Isot       Date:  2000-09       Impact factor: 1.513

7.  The low-energy β(-) and electron emitter (161)Tb as an alternative to (177)Lu for targeted radionuclide therapy.

Authors:  Silvia Lehenberger; Christoph Barkhausen; Susan Cohrs; Eliane Fischer; Jürgen Grünberg; Alexander Hohn; Ulli Köster; Roger Schibli; Andreas Türler; Konstantin Zhernosekov
Journal:  Nucl Med Biol       Date:  2011-04-20       Impact factor: 2.408

8.  Positional biliary stasis: scintigraphic findings following biliary-enteric bypass surgery.

Authors:  M H Lucas; A H Elgazzar; D D Cummings
Journal:  J Nucl Med       Date:  1995-01       Impact factor: 10.057

  8 in total
  3 in total

1.  [nat/44Sc(pypa)]-: Thermodynamic Stability, Radiolabeling, and Biodistribution of a Prostate-Specific-Membrane-Antigen-Targeting Conjugate.

Authors:  Lily Li; María de Guadalupe Jaraquemada-Peláez; Eduardo Aluicio-Sarduy; Xiaozhu Wang; Dawei Jiang; Meelad Sakheie; Hsiou-Ting Kuo; Todd E Barnhart; Weibo Cai; Valery Radchenko; Paul Schaffer; Kuo-Shyan Lin; Jonathan W Engle; François Bénard; Chris Orvig
Journal:  Inorg Chem       Date:  2020-01-24       Impact factor: 5.165

Review 2.  Production of scandium radionuclides for theranostic applications: towards standardization of quality requirements.

Authors:  R Mikolajczak; S Huclier-Markai; C Alliot; F Haddad; D Szikra; V Forgacs; P Garnuszek
Journal:  EJNMMI Radiopharm Chem       Date:  2021-05-25

3.  Production, biodistribution, and dosimetry of (47)Sc-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene phosphonic acid as a bone-seeking radiopharmaceutical.

Authors:  Fatemeh Fathi; Leila Moghaddam-Banaem; Mojtaba Shamsaei; Ali Samani; Mohammad G Maragheh
Journal:  J Med Phys       Date:  2015 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.